← Leaderboards
Shannon Talli Smith
Vanderbilt University
$105,596
Attributed
$105,596
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.2K · FY2019–22$50K$37.5K$25K$12.5K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$105,596 · 1
By mechanism
F31$105,596 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Richard M Caprioli$30,630,395
- Alfred L George$44,065,377
- Charles R Sanders$26,646,067
- Daniela Drummond-Barbosa$9,345,648
- Craig Lindsley$38,671,033
Others in their field
Other Emerging Leaders on “Computing Methodologies”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Michael W Rabin · Florida State University$26,502,247
- Eric C Palm · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Leonard Freedman · Leidos Biomedical Research, Inc.$25,149,318
- Neil King · University Of Washington$13,470,360
Research focus
Computing MethodologiesAmino AcidsAmino Acid TransporterAlanineAnti-Cancer TherapeuticArtificial Neural NetworkBaseBindingBiologicalAlgorithmsCancer TypeCell ProliferationCellsCheminformaticsChemistryCodeCommunitiesComplexComputational ChemistryComputational TechniqueComputer AssistedBiologyComputer SoftwareComputing Resources
Grant awards (3)
Hybridized structure- and ligand- based drug discovery approaches targeting ASCT2, an amino acid transporter critical for upregulated cell proliferation in numerous cancer types$30,122
F31 · FY2022 · CA · contact PI
Hybridized structure- and ligand- based drug discovery approaches targeting ASCT2, an amino acid transporter critical for upregulated cell proliferation in numerous cancer types$38,247
F31 · FY2021 · CA · contact PI
Hybridized structure- and ligand- based drug discovery approaches targeting ASCT2, an amino acid transporter critical for upregulated cell proliferation in numerous cancer types$37,227
F31 · FY2019 · CA · contact PI